Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PH-797804

Generic Name: PH-797804

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₁₉BrF_₂N_₂O_₃

CAS Number: 586379-66-0

Unique Ingredient Identifier: SI09I1V827

Overview

PH-797804 has been investigated for the treatment of Osteoarthritis.

Background

PH-797804 has been investigated for the treatment of Osteoarthritis.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

PH-797804 LPS Study in Healthy Volunteers

Phase 1

Completed

Posted: 2014/03/12

Sponsor:Pfizer

ID:NCT02084485

A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804

Phase 1

Withdrawn

Posted: 2013/08/16

Sponsor:Pfizer

ID:NCT01924650

A Study to Investigate the Effect of PH-797804 on QTc Interval

Phase 1

Completed

Posted: 2013/05/27

Sponsor:Pfizer

ID:NCT01862887

A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804

Phase 1

Completed

Posted: 2012/05/02

Sponsor:Pfizer

ID:NCT01589614

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide

Phase 2

Completed

Posted: 2012/03/05

Sponsor:Pfizer

ID:NCT01543919

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy